Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and parkinsonism-dementia complex of Guam: Specific pathological features

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 4, 2001, Pages 393-402

  Oyanagi, Kiyomitsu ^a   Tsuchiya, Kuniaki ^c   Yamazaki, Mineo ^a,b   Ikeda, Kenji ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

Author keywords

Corticobasal degeneration; Guam; Morphometry; Neuropathology; Parkinsonism dementia complex; Progressive supranuclear palsy; Substantia nigra

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ARGYROPHILIA; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE MUTATION; GUAM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPIL; PARKINSON DISEASE; PATHOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SPHEROID CELL; SUBSTANTIA NIGRA;

EID: 0035062957     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.4.393     Document Type: Article

References (66)

1. Neuropathology of movement disorders
2. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders
3. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia
4. Topographic investigation of brain atrophy in parkinsonism-dementia complex of Guam: A comparison with Alzheimer's disease and progressive supranuclear palsy
5. Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging
6. Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: A quantitative analysis of six cases
7. Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome
8. Ultrastructure of neurofibrillary tangles in progressive supranuclear palsy
9. Occurrence of 15-nm-wide straight tubules in neocortical neurons in progressive supranuclear palsy
10. Glial inclusions in CNS degenerative diseases
11. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration
12. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease
13. Glial tau pathology in neurodegenerative diseases: Their nature and comparison with neuronal tangles
14. Immunohistochemical and immunoelectron microscopical investigation of tau-positive neurons lacking tangle-formation in progressive supranuclear palsy
15. Peculiar axonal debris with subsequent astrocytic response (foamy spheroid body)
16. Grumose or foamy spheroid bodies involving astrocytes in the human brain
17. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease
18. Corticodentatonigral degeneration with neuronal achromasia
19. Corticobasal degeneration
20. Corticonigral degeneration with neuronal achromasia. A clinicopathologic study of two cases
21. Corticobasal degeneration: Etiopathological significance of the cytoskeletal alterations
22. Widespread cytoskeletal pathology characterizes corticobasal degeneration
23. Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features
24. Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features
25. Parkinsonism-dementia
26. Alzheimer's neurofibrillary changes. A topographic study
27. Amyotrophic lateral sclerosis of Guam: The nature of the neuropathological findings
28. The neostriatum and nucleus accumbens in parkinsonism-dementia complex of Guam: A pathological comparison with Alzheimer's disease and progressive supranuclear palsy
29. Distinct pathological features of the Gallyas- and tau-positive glia in the parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam
30. Neuropathology of parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam: An update
31. Identification of phosphorylation sites in PHF-tau from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex
32. Selective decrease of large neurons in the neostriatum in progressive supranuclear palsy
33. An autopsy case of progressive supranuclear palsy with echolalia showing psychiatric symptoms at the beginning
34. Serial brain CT in corticobasal degeneration: Radiological and pathological correlation of two autopsy cases
35. Basal ganglia lesions in corticobasal degeneration differ from those in Pick's disease and progressive supranuclear palsy: A topographic neuropathological study of six autopsy cases
36. Distribution of cerebral cortical lesions in corticobasal degeneration: A clinico-pathological study of five autopsy cases in Japan
37. A quantitative investigation of the substantia nigra in Huntington's disease
38. Silver staining of Alzheimer's neurofibrillary changes by means of physical development
39. Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment
40. Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease
41. Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: Identification of hidden and cleaved tau epitopes and a new phosphorylation site
42. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
43. Immunohistochemical study of the striatal efferents and nigral dopaminergic neurons in parkinsonism-dementia complex on Guam in comparison with those in Parkinson's and Alzheimer's diseases
44. Substantia nigra and locus ceruleus in parkinsonism-dementia complex on Guam and olivo-pontocerebellar atrophy
45. Evidence for a GABAergic nigrothalamic pathway in the rat. I. Behavioural and biochemical studies
46. GABAergic neurotransmission within the reticular part of the substantia nigra (SNR): Role for switching motor patterns and performance of movements
47. Collateral projection from the substantia nigra to the striatum and superior colliculus in the rat
48. Modification of saccadic eye movements by GABA-related substances. I. Effect of muscimol and bicuculline in monkey superior colliculus
49. Modification of saccadic eye movements by GABA-related substances. II. Effects of muscimol in monkey substantia nigra pars reticulata
50. The afferent and efferent connections of the feline nucleus tegmenti pedunculopontinus, pars compacta
51. Non-dopaminergic neurons in the substantia nigra project to the reticular formation around the trigeminal motor nucleus in the rat
52. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata
53. Correspondence between the dopamine islands and striosomes of the mammalian striatum
54. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems
55. Nucleus raphe dorsalis in parkinsonism dementia complex
56. Loss of pedunculopontine neurons in progressive supranuclear palsy
57. A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, parkinson patients, and schizophrenics
58. Zur pathologie der paralysis agitans und des postenzephalitischen parkinsonismus
59. A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease
60. Dopaminergic neurotransmitter systems in Alzheimer's disease and Down's syndrome at middle age
61. The number of nerve cells in the substantia nigra in paralysis agitans
62. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method
63. Mutational analysis of the tau gene in progressive supranuclear palsy
64. The tau gene A0 allele and progressive supranuclear palsy